An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

George Dudnik, 36, was told he was far too young and fit to be diagnosed with cancer – but after a series of terrifying ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Immutep Ltd (ASX:IMM) has dosed the first patient of its Phase 3 TACTI-004 non-small cell lung cancer trial – the final stage ...

George Dudnik was diagnosed with stage four lung cancer in November – and was told he would die from it despite being ...

Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...

July 17, 2024 — A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new ... New Study Finds 40-Percent of ...

George Dudnik has been given a stage four lung cancer diagnosis and has been bluntly told he will die from the disease – and ...

Immutep (ASX:IMM) has dosed the first patient in its pivotal Phase III trial evaluating eftilagimod alfa (efti) for the ...

Chemotherapy (with the ingredient deruxtecan ... HER2-low breast cancer unresectable or metastatic non-small cell lung cancer with activating HER2 mutations (changes in HER2 that make the protein ...

Hospitals in the Netherlands are increasingly concerned about the availability of various types of agents that form the basis ...